PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer

Triple negative breast cancer (TNBC), is defined as a type of tumor lacking the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). The ER, PR and HER2 are usually the molecular therapeutic targets for breast cancers, but they are ine...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Henan, Li, Duojiao, Zhang, Baojing, Qi, Yan, Diao, Yunpeng, Zhen, Yuhong, Shu, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149800/
https://www.ncbi.nlm.nih.gov/pubmed/29261144
http://dx.doi.org/10.3390/molecules22122277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149800/
https://www.ncbi.nlm.nih.gov/pubmed/29261144
http://dx.doi.org/10.3390/molecules22122277

Ejemplares similares